AI assistant
UroGen Pharma Ltd. — Director's Dealing 2019
Jan 10, 2019
32312_dirs_2019-01-10_05826247-901e-4c11-8f0f-346620d9accb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2019-01-01
Reporting Person: Belldegrun Arie (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 84211 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.00 | 2022-09-01 | Ordinary Shares (3241) | Direct | |
| Stock Option (right to buy) | $4.02 | 2019-10-14 | Ordinary Shares (128000) | Direct | |
| Stock Option (right to buy) | $5.00 | 2021-07-27 | Ordinary Shares (3241) | Direct | |
| Stock Option (right to buy) | $5.00 | 2022-10-07 | Ordinary Shares (160000) | Direct | |
| Stock Option (right to buy) | $43.67 | 2028-01-10 | Ordinary Shares (20000) | Direct | |
| Stock Option (right to buy) | $59.23 | 2028-06-04 | Ordinary Shares (10000) | Direct |
Footnotes
F1: Fully vested.
F2: 25% of the shares underlying the stock option vested on each of October 13, 2012, October 13, 2013, October 13, 2014 and October 13, 2015.
F3: 25% of the shares underlying the stock option vested on each of October 7, 2016, October 7, 2017 and October 7, 2018 and the remaining 25% of the shares will vest on October 7, 2019.
F4: 25% of the shares underlying the stock option vested on each of April 10, 2018, July 10, 2018 and October 10, 2018 and the remaining 25% of the shares will vest on January 10, 2019.
F5: 25% of the shares underlying the stock option vested on each of September 4, 2018 and December 4, 2018 and the remaining shares will vest 25% on each of March 4, 2019 and June 4, 2019.